Affinity Asset Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-50,000	Closed	-$5.53M	–	99
2025 Q1	$5.53M	Buy	+50,000	New	+$5.53M	0.53%	30
2024 Q1	–	Sell	-10,000	Closed	-$1.32M	–	98
2023 Q4	$1.32M	Buy	+10,000	New	+$1.32M	0.24%	56